EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

Sex: All

Ages: 40 Years – 75 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 22

Sponsor: Wake Forest University Health Sciences

Location: Wake Forest University Health Sciences Winston-Salem North Carolina

Summary

The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).

Eligibility Criteria

Inclusion Criteria: * Emergency Department (ED) patients with chest pain * 40-75 years old * a low-density lipoprotein cholesterol (LDL-C) ≥70 mg/dL on an ED lipid panel or have known diabetes or Atherosclerotic Cardiovascular Disease (ASCVD) Exclusion Criteria: * Subject unwilling to take study medication * Pregnancy or breastfeeding * Inability to take study medication or, in the opinion of the Investigators/subject's doctors unsuitable for study participation * ST-Segment Elevation Myocardial Infarction (STEMI) Activation * ST-Segment Depression \>1 mm * On a Lipid Lowering Agent (Statin, PCSK9 Inhibitor, Bempedoic Acid, Ezetimibe, Inclisiran) * Unstable Vitals (Blood Pressure (BP) \120 or \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05742841). StuddyBuddy aggregates publicly available trial information.